Cortisol metabolism by 11 beta-hydroxysteroid dehydrogenase as a novel target in the treatment of inflammation- or immune-mediated bone loss: comment on the article by Makrygiannakis et al

Arthritis Rheum. 2007 Jan;56(1):387-8. doi: 10.1002/art.22318.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • 11-beta-Hydroxysteroid Dehydrogenases / metabolism*
  • Anti-Inflammatory Agents / therapeutic use*
  • Arthritis / drug therapy*
  • Arthritis / metabolism
  • Bone Resorption / drug therapy*
  • Bone Resorption / enzymology
  • Down-Regulation
  • Humans
  • Hydrocortisone / metabolism*
  • Inflammation / drug therapy*
  • Inflammation / enzymology
  • Injections, Intra-Articular
  • Triamcinolone Acetonide / analogs & derivatives*
  • Triamcinolone Acetonide / therapeutic use

Substances

  • Anti-Inflammatory Agents
  • 11-beta-Hydroxysteroid Dehydrogenases
  • Triamcinolone Acetonide
  • triamcinolone hexacetonide
  • Hydrocortisone